Ionis Pharmaceuticals, Inc. (IONS) Net margin 2016–2025
Ionis Pharmaceuticals, Inc. (IONS) net profit margin by fiscal year — reported net income divided by reported revenue.
-40.4%FY2025 · since FY2016: -16.2% → -40.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -40.4% | +24.0 pp |
| FY2024 | -64.4% | -17.9 pp |
| FY2023 | -46.5% | -0.6 pp |
| FY2022 | -45.9% | -42.4 pp |
| FY2021 | -3.5% | +57.4 pp |
| FY2020 | -60.9% | -85.7 pp |
| FY2019 | 24.8% | -20.9 pp |
| FY2018 | 45.6% | +45.6 pp |
| FY2017 | 0.1% | +16.3 pp |
| FY2016 | -16.2% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More IONS financial trends
IONS RevenueIONS Net incomeIONS Gross profitIONS Gross marginIONS Operating incomeIONS Operating marginIONS Operating cash flowIONS Free cash flowIONS Capital expendituresIONS Return on equityIONS Stock buybacksIONS Dividends paidIONS Total assetsIONS Total liabilitiesIONS Shareholders’ equityIONS overview →